Blankpeptides.com is the next RUO website I was sent to look into. At first glance, it does everything right. Minimal branding. Neutral colours. No clutter. No loud claims splashed everywhere. The message is simple:
Pure. Premium. Peptides.
Nothing more. Nothing less.
After looking at the previous site that relied on obviously fake COAs, this one takes a different approach. On the surface, the COAs here appear more legitimate. They’re all from Freedom Diagnostics, a recognised third-party lab, which immediately gives a stronger impression of credibility, but once you start looking properly, a different pattern emerges. This one isn’t about fake documents, it’s about constructed credibility.
First Impressions
The website is gated, requiring email verification just to enter, but once inside, what stands out immediately is the bold claims on the homepage:
Trusted by 500+ clinics nationwide
12,400+ vials delivered
>99% pharmaceutical grade
Scrolling further, there are three 5-star reviews from “verified buyers.” They read less like real customer feedback and more like brand copy. Elsewhere on the site, more claims appear:
3+ years in research, 50+ institutions served and 99.8% purity satisfaction
From this alone, it presents as a well-established company, until i checked the WHOIS.
The Timeline Problem
This is where the illusion starts to fall apart, the WHOIS record shows:
Domain created: 4 March 2026 and Updated: 11 March 2026
That’s recent. Now comparing that to the claims, 12,400+ vials delivered, 500+ clinics served, 3+ years in research and 99.8% purity satisfaction, those numbers imply scale, history, and an established operation. So the obvious question is, how does a domain registered in March 2026 already have years of activity and thousands of orders behind it? There are only a few possibilities, either it’s a rebrand of an older business, it operated elsewhere before launching the site or the numbers are fictitious and unverified. If it’s a continuation, there should at least be evidence of that, but there isn’t.
The COAs; Better, But Still Not What They Seem
Unlike the last site, this one does provide third-party COAs, all from Freedom Diagnostics. Most of the more popular products have attached COAs for mass, purity and endotoxins. The COAs look legitimate showing HPLC data, mass spectrometry traces, endotoxin testing and proper lab formatting. That’s real data, but look at the timing. Across multiple products:
Received date: 04/06/2026
Reported date: 04/07/2026
Everything was tested at the same time. That’s not what ongoing quality control looks like, but it looks more like a new vendor sending multiple products at once for initial testing, which aligns perfectly with the March 2026 domain, the lack of historical data and the absence of batch continuity. So instead of supporting “years of experience,” the COAs suggest that this operation is very recent.
Selective Proof
Not all products have COAs available, yet many still display: “>99% purity” and “No endotoxins or heavy metals” with no supporting data. This means the purity claim isn’t tied to visible testing, it’s applied regardless as, No COA, same claim. That’s not verification, that’s templating.
Pricing
The site claims:
By removing the "premium" branding fees, wasteful marketing, and unnecessary expenses, we redirect every dollar toward synthesis precision.
But the pricing tells a different story. Examples:
Retatrutide 10mg, $130 per vial
Tirzepatide 10mg, $95 per vial
AOD 5mg - $65 per vial
These are per-vial prices, not bulk or kit-level pricing, so instead it sits firmly in premium reseller territory. In fact, these prices exceed what entire multi-vial kits cost at source, which contradicts their earlier claim. Stripped-back branding but not stripped-back pricing.
Pressure Tactics
Another thing that stood out in this site is how it uses urgency throughout, with countdown timers:
“Order within 12h…” , phrases such as “Ships today” and “Only 38 vials remaining”
That raises a simple question that if their inventory is turning over that fast, why are the COAs all from the same early batch?
There’s also no way to verify any of this and instead, these elements exist to do one thing, and that’s to reduce hesitation.
Social Proof Without Proof
Product pages also display activity claims such as:
“75 researchers ordered this week”
It’s presented as real-time demand, but there’s nothing to support it. It also doesn’t behave like real-time data because when I checked again the following day, the number on Retatrutide was still the same despite the number of vials remaining going down.
KPV, a far more niche product, was showing 130 researchers ordered this week, almost double Retatrutide.
Maybe that’s possible, but it seems unlikely.
Combined with high per-vial pricing, limited COAs, and strong purity claims, these numbers look less like transparent sales data and more like social proof built into the page. Most buyers aren’t going to spend hundreds testing a single vial after already paying premium prices, so instead of verification, the site relies on perception.
Testimonials & Authority Signals
The site includes named endorsements:
Dr. Julian Kessler, Biomatrix Labs
Anika S. Singh, Synthetics Quality Control
Prof. David Emmerich, Applied Peptide Research
These are presented as authority figures, but there’s no way to verify them, no institutional links, no publications and no connection to actual data. Even “Biomatrix” is unclear. A real company exists in India, but there’s no evidence linking it to this site.
At the same time, these testimonials reference, “detailed MS and HPLC data,” which isn’t actually shown in a meaningful, traceable way. Named unknown experts, with no way to verify them.
The cGMP Claim
The site claims cGMP-compliant manufacturing. That’s a serious claim, but there’s no facility named, no certification, no regulator and no way to verify it. cGMP isn’t branding, and as I’ve explained in a previous post, a GMP claim only means something if you can trace the facility, the certification, and the scope of what was actually certified, all of which requires scrutiny which is exactly what the grey market avoids.
And based on everything else already visible about this company, the new domain, inflated history claims, selective proof, pressure tactics, and unverifiable endorsements, the idea that it’s genuinely working through a properly compliant GMP manufacturing route feels far fetched to say the least.
RUO vs Reality
The phrase appears several times across the site:
“For research use only. Not for human consumption.”
But like many RUO websites, the disclaimer says one thing while the rest of the site points somewhere else. Blank compares itself to 503A pharmacies, offers wholesale access for clinics, targets med spas and wellness centres, and uses clinical-style product positioning. The application process even asks users to select whether they are a Medical Clinic, Medical Spa, Wellness Centre, or Research Institution.
The product pages also lean into human-use categories and outcomes. The catalogue includes areas such as Sexual Health, Metabolic Regulation, Regeneration & Recovery, Growth Hormone Axis Research, Cellular Health & Longevity, and Skin, Hair & Aesthetic Research.
On individual pages, the wording goes further. Retatrutide is discussed in relation to weight reduction, hepatic fat reduction, and GLP-1/GIP/glucagon receptor pathways. PT-141 is described around sexual health. Selank is presented as an anxiolytic neuropeptide for anxiety and stress research. SS-31 is framed around aging and energy research.
This is something that can potentially draw unwanted attention from the FDA. RUO in the footer, human-use marketing everywhere else.
Positioning Itself as Better Than 503A
One of the clearest signals is the site’s direct comparison with 503A compounding pharmacies. This isn’t a neutral side-by-side. It’s framed to make Blank look like the better option. 503A pharmacies are presented as restricted, inconsistent, slower and more expensive, while Blank positions itself as easier, faster, cheaper, more consistent and independently tested.
That’s not just comparison, it’s positioning itself as superior to a regulated pharmacy system, which is the issue. 503A pharmacies operate within a defined regulatory framework, with oversight, prescription requirements, and accountability built in. Blank, based on everything shown so far, a newly registered domain, inflated history claims, selective proof, unverified testimonials, and unsupported cGMP statements, doesn’t demonstrate any of that. Yet it’s presented as the better option.
Made in USA” Claims
The site also leans heavily on “US made peptides” and “US-based” positioning. That sounds reassuring, but there’s no detail behind it. Given everything else already established, the recent domain, batch-timed COAs, reseller-style pricing, and lack of traceable infrastructure, the claim raises more questions than it answers.
The Pattern
Each issue on its own may not prove anything, but together, they form a clear pattern: credibility built through design, not through data.
In Simple Terms
This site doesn’t rely on obviously fake documents, it doesn’t need to. Instead, it uses just enough real data, just enough technical language and just enough authority signal to create confidence, without full transparency.
The COAs look real. The story doesn’t.
In a statement from Blankpeptides, they say the D2C website is recent, but the business is not, and that they have been supplying wholesale to clinics and companies around the country for several years.
They claim to work with multiple cGMP labs in Missouri, Alabama, Florida, and Texas to secure supply.
If there is publicly verifiable documentation supporting those claims, I’m happy to review it
Comments